BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16282834)

  • 1. A preliminary case series on the use of quetiapine for posttraumatic stress disorder in juveniles within a youth detention center.
    Stathis S; Martin G; McKenna JG
    J Clin Psychopharmacol; 2005 Dec; 25(6):539-44. PubMed ID: 16282834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.
    Hamner MB; Deitsch SE; Brodrick PS; Ulmer HG; Lorberbaum JP
    J Clin Psychopharmacol; 2003 Feb; 23(1):15-20. PubMed ID: 12544370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine therapy for posttraumatic stress disorder.
    Sattar SP; Ucci B; Grant K; Bhatia SC; Petty F
    Ann Pharmacother; 2002 Dec; 36(12):1875-8. PubMed ID: 12452747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder.
    Sokolski KN; Denson TF; Lee RT; Reist C
    Mil Med; 2003 Jun; 168(6):486-9. PubMed ID: 12834142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.
    Kozaric-Kovacic D; Pivac N
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.
    Ahearn EP; Mussey M; Johnson C; Krohn A; Krahn D
    Int Clin Psychopharmacol; 2006 Jan; 21(1):29-33. PubMed ID: 16317314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety.
    Byers MG; Allison KM; Wendel CS; Lee JK
    J Clin Psychopharmacol; 2010 Jun; 30(3):225-9. PubMed ID: 20473055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series.
    Baig MR; Wilson JL; Lemmer JA; Beck RD; Peterson AL; Roache JD
    Psychiatr Q; 2019 Jun; 90(2):431-445. PubMed ID: 31054021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
    El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of atypical antipsychotic medications for posttraumatic stress disorder.
    Ahearn EP; Juergens T; Cordes T; Becker T; Krahn D
    Int Clin Psychopharmacol; 2011 Jul; 26(4):193-200. PubMed ID: 21597381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.
    Bandelow B; Chouinard G; Bobes J; Ahokas A; Eggens I; Liu S; Eriksson H
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):305-20. PubMed ID: 19691907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study.
    Robert S; Hamner MB; Kose S; Ulmer HG; Deitsch SE; Lorberbaum JP
    J Clin Psychopharmacol; 2005 Aug; 25(4):387-8. PubMed ID: 16012285
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Quetiapine Monotherapy in Posttraumatic Stress Disorder: A Randomized, Placebo-Controlled Trial.
    Villarreal G; Hamner MB; Cañive JM; Robert S; Calais LA; Durklaski V; Zhai Y; Qualls C
    Am J Psychiatry; 2016 Dec; 173(12):1205-1212. PubMed ID: 27418378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing the Effects of Quetiapine in Military Post-Traumatic Stress Disorder.
    Villarreal G; Hamner MB; Qualls C; Cañive JM
    Psychopharmacol Bull; 2018 Feb; 48(2):8-17. PubMed ID: 29713096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine reduces flashbacks in chronic posttraumatic stress disorder.
    Filteau MJ; Leblanc J; Bouchard RH
    Can J Psychiatry; 2003 May; 48(4):282-3. PubMed ID: 12776399
    [No Abstract]   [Full Text] [Related]  

  • 19. Quetiapine in nine youths with autistic disorder.
    Findling RL; McNamara NK; Gracious BL; O'Riordan MA; Reed MD; Demeter C; Blumer JL
    J Child Adolesc Psychopharmacol; 2004; 14(2):287-94. PubMed ID: 15319025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E; Lemelin S
    J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.